Experts Endorse Approval of Alzheimer’s Drug
A major milestone was crossed on Friday, as health advisers frequently endorsed the full approval of Leqembi, a highly anticipated Alzheimer’s drug. The roads are now paved for insurance coverage to be provided to seniors in the US who suffer from early stages of this debilitating disease. Leqembi had previously only received conditional approval by …